Arlene Morris

Arlene M.
Morris is currently Chief Executive Officer at Willow Advisors LLC since 2015.
Serving as Chairman at TC Biopharm (Holdings) Plc since 2023.
Chairman-Research & Development Foundation at Medical University of South Carolina Foundation.
Independent Director at Palatin Technologies, Inc. since 2015, Viveve, Inc. since 2016, Cogent Biosciences, Inc. since 2019, Viridian Therapeutics, Inc. since 2018, and Edgewise Therapeutics, Inc. since 2024.
Director at Charleston Animal Society since 2022.
Former roles include President, Chief Executive Officer & Director at Syndax Pharmaceuticals, Inc. from 2012 to 2015; President, Chief Executive Officer & Director at Affymax, Inc. from 2003 to 2011; President & Chief Executive Officer at Clearview Projects, Inc. from 2002 to 2004; Chairman at Nuon Therapeutics, Inc.; Independent Director at MediciNova, Inc. from 2011 to 2013; Director at Biodel, Inc. from 2015 to 2016; Director at Biotechnology Innovation Organization from 2006 to 2011; Director at MUSC Foundation for Research Development from 2012 to 2022; Director at Humane Society of Silicon Valley from 2009 to 2011; Independent Director at Dimension Therapeutics, Inc. from 2015 to 2018; Director at Neovacs, Inc. from 2011 to 2021; Independent Director at Viveve Medical, Inc. from 2016 to 2022; Independent Director at Neovacs SA from 2011 to 2021; Senior Vice President-Business Development at Coulter Pharmaceuticals, Inc. from 1996 to 2001; Trustee at Carlow University Of from 2016 to 2022; Senior Vice President-Business Development at Scios, Inc. from 1993 to 1996; Vice President-Business Development at Johnson & Johnson from 1977 to 1993.
Education includes undergraduate studies at Carlow College and Western New England University.